Several state legislatures are debating vaccine-related measures as dozens of people have fallen ill from a measles outbreak that started at Disneyland in December and spread beyond the theme park. Here is a look at some of the legislation around the country. Read more...

Can A.D.H.D. drugs help “normalize“ a child’s brain? Recent research suggests that A.D.H.D. medication may regulate the brain over time, rewiring neural connections, so that the focus and in-control effect endures. Read more...

A new study by the Centre for Addiction and Mental Health (CAMH) found that the measure of brain inflammation in people who were experiencing clinical depression was increased by 30 percent. The findings, published today in JAMA Psychiatry, have important implications for developing new treatments for depression. Read more..

Being able to predict that a patient will adversely react to a drug that's meant to be treating them is a key aim of personalized medicine, and could help to improve the patient's overall treatment. Read more...

MRIGlobal announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials. Read more...

For the first time, scientists have found evidence of neuroinflammation in key regions of the brains of patients with chronic pain, according to a new study from Massachusetts General Hospital (MGH), a Harvard affiliate. Read more...

A number of open access journals have made the news recently. The preprint open access archive, arXiv.org, run by Cornell University, is often used by scientists, from physicists to quantitative biologists, to get their ideas out there quickly and stake out their intellectual ground, before they enter the slow process of peer review. Read more...

In early 2013, adaptive clinical trials represented 20% of all clinical trials, according to the Tufts CSDD seminal report, The Adoption and Impact of Adaptive Trial Designs. Though that number was expected to grow, lack of education and industry conservatism were named as some of the greatest barriers to widespread adoption of adaptive designs. Read more...

A clinical drug trial is now under way at a major health center in Liberia's capital to determine if a medication already used to treat other viruses could help those suffering from Ebola. Read more...